ACADIA Pharmaceuticals
ACAD
#3767
Rank
C$4.83 B
Marketcap
C$28.21
Share price
-1.01%
Change (1 day)
-7.76%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): C$0.19 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are C$1.07 Billion. a decrease over its 2024 earnings that were of C$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 C$0.19 B-46.18%
2024 C$0.35 B-605.67%
2023 -C$70.31 Million-76.09%
2022 -C$0.3 Billion27.41%
2021 -C$0.24 Billion-40.38%
2020 -C$0.39 Billion19.88%
2019 -C$0.33 Billion-3.92%
2018 -C$0.34 Billion-15.04%
2017 -C$0.4 Billion6.33%
2016 -C$0.38 Billion64.55%
2015 -C$0.23 Billion77.47%
2014 -C$0.13 Billion143.69%
2013 -C$52.28 Million81.93%
2012 -C$28.74 Million-8.73%
2011 -C$31.49 Million-251.39%
2010 C$20.79 M-133.2%
2009 -C$62.64 Million-30.82%
2008 -C$90.55 Million6.43%
2007 -C$85.08 Million25.89%
2006 -C$67.58 Million36.99%
2005 -C$49.33 Million37.22%
2004 -C$35.95 Million19.96%
2003 -C$29.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.78 B 18,602.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.59 B 7,524.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$42.87 B 22,307.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.22 B 6,809.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-C$0.17 Billion-187.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-C$53.22 Million-127.81%๐Ÿ‡บ๐Ÿ‡ธ USA